Bloom Health Partners Inc (CSE:BLMH, OTCQB:BLMHF) has reported a significant jump in revenue for fiscal 3Q, nearly reaching its full-year revenue guidance in just three quarters.
Bloom CEO Andrew Morton said the company’s 3Q revenue of C$8.4 million and aggregate C$24.9 million for the year-to-date has resulted in the company all but reaching its revenue guidance for the 2022 financial year of C$25 million to C$28 million with one quarter left to go.
“We're proud of our team's performance so far this year as we continue to transition Bloom into an innovative provider of employer health-tech solutions and services,” he said.
READ: Bloom Health Partners announces new Chicago location, closes final tranche of placement for gross proceeds of C$75,000
“Our end-to-end platform strategy of clinical, labs and data in workplace health is well received by clients, partners and investors."
The company's C$8.4 million revenue for the three months ended June 30, 2022 compares to the C$10,940 achieved in the year-ago quarter.
Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was $1.4 million, compared to a negative EBITDA of $1.1 million for the same period last year.
The company narrowed its net loss to C$620,296 or C$0.02 per share from a loss of C$1.1 million or C$0.03 per share for the same period in 2021.
Bloom is a global platform for healthcare security, diagnostic testing, and occupational health tech whose mission is to ensure that “unstoppable is possible” for businesses and their employees through innovative, customized healthcare models.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie